Eric L. Keller Insider Trades
CEOCEO at Retension Pharmaceuticals, Inc.. 1 significant open-market trade reported on SEC Form 4 in the last 180 days.
On EDGAR, this filer has 2 Form 4 filings on record since 2026, the latest on Oct 22, 2026. Full history on sec.gov
$250K
Bought
$0
Sold
1 / 0
Buys / Sells
1
Companies
Companies
- RTSNCEO
Retension Pharmaceuticals, Inc.
1 buy, $250K
Reported Trades
Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.
| Filed | Company | Trade | Value |
|---|---|---|---|
| Oct 13, 2026 | RTSNCEO | buy | $250K |
Other Insiders at These Companies
Everyone else who reported a significant open-market trade at the same company in the last 180 days. Several insiders buying at once is cluster buying.
- Franklin M. BergerDirector at RTSN1 buy, $120K
How to Read This Page
These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. The window here is 180 days; the full filing history lives on EDGAR. This record has fewer than 2 trades under $500K, so it is not yet listed on the hub.
Get this insider's next buy when it files
InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.
Try free for 7 daysEvery alert we send is logged with its timestamp and source.